This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Phillips, P. A. Articles by Saluja, A. K. Search for Related Content PubMed PubMed Citation Articles by Phillips, P. A. Articles by Saluja, A. K.

Triptolide Induces Pancreatic Cancer Cell Death via Inhibition of Heat Shock Protein 70

¹ Department of Surgery, University of Minnesota, Minneapolis, Minnesota and ² Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama

Requests for reprints: Ashok K Saluja, Department of Surgery, University of Minnesota, 420 Delaware Street, Minneapolis, MN 55488. Phone: 612-624-8108; E-mail: asaluja{at}umn.edu.

Pancreatic cancer is highly resistant to current chemotherapy agents. We therefore examined the effects of triptolide (a diterpenoid triepoxide) on pancreatic cancer growth and local-regional tumor spread using an orthotopic model of pancreatic cancer. We have recently shown that an increased level of HSP70 in pancreatic cancer cells confers resistance to apoptosis and that inhibiting HSP70 induces apoptosis in these cells. In addition, triptolide was recently identified as part of a small molecule screen, as a regulator of the human heat shock response. Therefore, our aims were to examine the effects of triptolide on (a) pancreatic cancer cells by assessing viability and apoptosis, (b) pancreatic cancer growth and local invasion in vivo, and (c) HSP70 levels in pancreatic cancer cells. Incubation of PANC-1 and MiaPaCa-2 cells with triptolide (50–200 nmol/L) significantly reduced cell viability, but had no effect on the viability of normal pancreatic ductal cells. Triptolide induced apoptosis (assessed by Annexin V, caspase-3, and terminal nucleotidyl transferase–mediated nick end labeling) and decreased HSP70 mRNA and protein levels in both cell lines. Triptolide (0.2 mg/kg/d for 60 days) administered in vivo decreased pancreatic cancer growth and significantly decreased local-regional tumor spread. The control group of mice had extensive local invasion into adjacent organs, including the spleen, liver, kidney, and small intestine. Triptolide causes pancreatic cancer cell death in vitro and in vivo by induction of apoptosis and its mechanism of action is mediated via the inhibition of HSP70. Triptolide is a potential therapeutic agent that can be used to prevent the progression and metastases of pancreatic cancer. [Cancer Res 2007;67(19):9407–16]

This article has been cited by other articles:

				V Dudeja, S M Vickers, and A K Saluja The role of heat shock proteins in gastrointestinal diseases Gut, July 1, 2009; 58(7): 1000 - 1009. [Abstract] [Full Text] [PDF]

				C. A. Martin, D. L. Kurkowski, A. M. Valentino, and F. Santiago-Schwarz Increased Intracellular, Cell Surface, and Secreted Inducible Heat Shock Protein 70 Responses Are Triggered during the Monocyte to Dendritic Cell (DC) Transition by Cytokines Independently of Heat Stress and Infection and May Positively Regulate DC Growth J. Immunol., July 1, 2009; 183(1): 388 - 399. [Abstract] [Full Text] [PDF]

				W. Zhu, Y. Ou, Y. Li, R. Xiao, M. Shu, Y. Zhou, J. Xie, S. He, P. Qiu, and G. Yan A Small-Molecule Triptolide Suppresses Angiogenesis and Invasion of Human Anaplastic Thyroid Carcinoma Cells via Down-Regulation of the Nuclear Factor-{kappa}B Pathway Mol. Pharmacol., April 1, 2009; 75(4): 812 - 819. [Abstract] [Full Text] [PDF]

				X. Shi, Y. Jin, C. Cheng, H. Zhang, W. Zou, Q. Zheng, Z. Lu, Q. Chen, Y. Lai, and J. Pan Triptolide Inhibits Bcr-Abl Transcription and Induces Apoptosis in STI571-resistant Chronic Myelogenous Leukemia Cells Harboring T315I Mutation Clin. Cancer Res., March 1, 2009; 15(5): 1686 - 1697. [Abstract] [Full Text] [PDF]